buthionine sulfoximine and glutathione synthesis - an overview Butionine sulfoximine DL-Buthionine-(S,R)-sulfoximine (Buthionine sulfoximine) | Glutamylcysteine

Roumeliotis S, Dounousi E, Eleftheriadis T, Liakopoulos V

Maloy KJ, Powrie F (2011) Intestinal homeostasis and its breakdown in inflammatory bowel disease

Ke A, Yang W, Zhang W, Chen Y, Meng X, Liu J, et al

TRANSCRIPTOMIC DIFFERENCES BETWEEN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS, WITH AND WITHOUT ULCERATIVE COLITIS Kiandokht Bashiri 1 Camille Boustani 2 Spyridon Peppas 3 Alireza Meighani 3 Won Kyoo Cho 4 , 1 Georgetown University/ MedStar Washington Hospital Center, 2 MedStar Georgetown University Hospital, 3 MedStar Washington Hospital Center, 4 Georgetown University School of Medicine Background: The majority of patients with Primary sclerosing cholangitis (PSC) develop ulcerative colitis (UC)

To address the major differences in glutaredoxin activities, we previously suggested two nonexclusive working models for glutaredoxin catalysis termed glutathione scaffold and glutathione activator model